Gastronaut GASTRONAUT
Initializing Mission Systems
1,042 growth cycles
///
28 Scopus papers
///
+1.86 SD Nrf2 activation
///
$487B TAM by 2040
///
600d Mars-ready
← Ocular Health
OCU-3 Evidence and Validation Roadmap

Build the Evidence Chain Before Flight

An image taken on flight day 30 may help NASA decide how closely to monitor an eye through flight day 150. In a study of 43 International Space Station crewmembers, retinal-thickness change at those...

An image taken on flight day 30 may help NASA decide how closely to monitor an eye through flight day 150. In a study of 43 International Space Station crewmembers, retinal-thickness change at those two timepoints correlated at 0.89 (95 percent confidence interval 0.80 to 0.94, P < 0.001). Eyes with less than 20 micrometers of change at day 30 had a 2 percent probability of reaching at least 55 micrometers by day 150. For eyes with 29 to 55 micrometers at day 30, the probability was 58 percent (Carter et al. 2026).

That result brings an ocular measurement close to an operational decision. A nutritional study would need to begin earlier. Baseline susceptibility, the production of a controlled exposure, measured intake, biochemical response, and ocular structure form a sequence in which each result determines what can responsibly be asked next. The sequence gives NASA four decision gates and gives Gastronaut a standard against which ORCA’s production, sensing, and traceability functions can be tested.

The evidence behind the sequence

Gastronaut’s ocular-health synthesis assessed 785 records and retained 388 analysable studies from 3,375 unique records. The corpus includes 100 human-spaceflight studies and 163 human ground-analog studies. Full-text retrieval did not run, so the synthesis makes statements bounded by the indexed abstracts rather than claims about the literature as a whole.

Baseline susceptibility supplies the first empirical thread. Zwart and colleagues studied 20 astronauts. Four one-carbon metabolites were 25 to 45 percent higher in the five crew members with ophthalmic changes than in the 15 without them, and the differences were present before, during, and after flight (Zwart et al. 2012). In a later analysis of 49 astronauts, B-vitamin status improved a model of refractive change at P < 0.001. The genetic contribution in that example reached P = 0.10 (Zwart et al. 2016). A European head-down-tilt cohort also associated MTRR and SHMT1 variants with retinal-thickness change; genotype combined with preflight optic cup volume predicted the response better than either measure alone (Zwart et al. 2024).

The record also identifies the work still required. In a flight case, B-vitamin supplementation coincided with a reduction in cabin carbon dioxide, so the effects remained confounded (Gastronaut). Mechanical-countermeasure studies often report fluid or pressure proxies, while five of 56 relevant records measured ocular structure. Of 21 randomized studies in the corpus, 19 were ground analogs. All eight randomized designs with an ocular structural endpoint were conducted at the ground-analog tier.

Confidence is moderate in the model of baseline susceptibility and high in the need to preserve endpoint and timing distinctions. Confidence in a nutritional efficacy estimate remains low because the evidence does not contain a controlled flight trial that links a nutritional exposure to a prespecified ocular structural outcome. A staged program converts those limits into decisions, while retaining the uncertainty each later stage inherits.

Decision 1: can the exposure be reproduced?

The first result belongs to the cultivation platform. Across repeated cycles, it would need to produce edible material with a prespecified composition. Seed lot, growth conditions, harvest time, analytical method, edible basis, storage, and preparation would stay attached to each result.

Success at this stage would establish production repeatability within the test conditions. It would leave intake, biochemical response, ocular response, and flight performance for later studies. That separation makes a production milestone useful on its own terms.

ORCA is a ground-stage platform at approximately TRL 3 to 4, with no flight or lunar operating history. A study-specific qualification campaign would define production variance, fault categories, and acceptable operating bounds for the proposed exposure. Its first service to the program would be a dependable account of what it produced and under which conditions.

Decision 2: what reached the participant?

The next result concerns exposure rather than cultivation. A randomized or controlled feeding study can record the amount offered, consumed, and left uneaten. Adherence, gastrointestinal tolerance, background diet, medication use, and relevant biochemical markers would remain part of the same study record.

At this point, edible material becomes a measured intake. The evidence may establish feasibility, tolerability, or a biochemical response. An ocular claim would still require an ocular endpoint and a design capable of supporting that inference. Keeping the handoff explicit protects the distinction between food-system performance and human response.

Decision 3: did ocular structure change with the exposure?

The third stage brings susceptibility and the eye into one design. Participants could be stratified by baseline biochemistry, genotype where ethically and scientifically justified, optic cup volume, refractive status, body composition, and other prespecified factors. Optical coherence tomography would use a declared instrument, acquisition protocol, and segmentation method.

A ground analog could test whether a controlled nutritional exposure changes a biochemical marker and whether that change accompanies a prespecified ocular response. Before enrollment, the protocol would establish its comparator, multiplicity plan, missing-data rules, and clinically meaningful effect threshold.

The result would describe the analog conditions and inform the design of flight research. Translation to flight would remain a separate test, entered with the analog’s uncertainty intact. That continuity lets the later team know which question it has inherited and which claim remains to be established.

Decision 4: can the finding guide operations?

Flight research would combine early inflight imaging, baseline susceptibility measures, controlled intake records, and environmental monitoring. Its decision question might ask whether an early measurement identifies crew members for a different monitoring schedule or a modified intervention plan.

The Carter study provides an example of an ocular measure framed around operational burden. A nutrition-focused extension would need prospective thresholds and validation in a separate cohort. Carbon dioxide, medication use, mission duration, countermeasure exposure, and timing would remain visible so the analysis can distinguish nutrition from conditions changing alongside it.

A protocol NASA can evaluate before enrollment

Gastronaut proposes a protocol package containing a data dictionary, provenance model, sampling schedule, comparator logic, safety boundaries, uncertainty plan, and claim map. NASA would retain responsibility for clinical endpoints and human-subject decisions. Gastronaut would be responsible for making the food and nutrient exposure reproducible and auditable.

Each decision would end with a plain account of what the evidence established, what remains interpretation, and what action the result can support. The program could then advance from cultivation to flight without asking an early result to carry a later claim. It would also leave the next study team a record fit for the responsibility it inherits, centred throughout on the crew members whose sight gives the work its purpose.

References

Carter, Connor R., et al. “Prediction of Optic Disc Edema Progression During Spaceflight.” JAMA Ophthalmology, 2026. https://doi.org/10.1001/jamaophthalmol.2025.4635.

Gastronaut. Ocular Health and Spaceflight-Associated Neuro-ocular Syndrome: Evidence Synthesis. Evidence version 22 Aug. 2026. Research synthesis.

Zwart, Sara R., et al. “Vision Changes After Spaceflight Are Related to Alterations in Folate- and Vitamin B-12-Dependent One-Carbon Metabolism.” The Journal of Nutrition, 2012. https://doi.org/10.3945/jn.111.154245.

Zwart, Sara R., et al. “Genotype, B-Vitamin Status, and Androgens Affect Spaceflight-Induced Ophthalmic Changes.” FASEB Journal, 2016. https://doi.org/10.1096/fj.15-278457.

Zwart, Sara R., et al. “Optic Disc Edema During Strict 6-Degree Head-Down Tilt Bed Rest Is Related to One-Carbon Metabolism Pathway Genetics and Optic Cup Volume.” Frontiers in Ophthalmology, 2024. https://doi.org/10.3389/fopht.2023.1279831.

Evidence boundary

This report separates established findings, Gastronaut's research synthesis, company assertions, and recommendations. Cited works remain attributed to their authors and publishers. ORCA is a ground-stage system at approximately TRL 3 to 4, with a documented ground operating record, no flight operating history, and no lunar operating history. Statements about ORCA capability are design objectives or proposed work unless a cited source establishes otherwise. Biological efficacy, flight qualification, NASA validation, and procurement remain future determinations.

Gastronaut welcomes a bounded technical exchange on the questions this report raises.

needtheinfo@gastronaut.earth